Topspin Biotech Fund II, L.P., 10% Owner at RAPT Therapeutics, Inc. (RAPT), bought 415,000 shares at $12.00 ($5.0M) on 2019-11-04, disclosed to the SEC on 2019-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.